Monsanto (MON) Posts Earnings Results, Misses Estimates By $0.01 EPS

Monsanto (NYSE:MON) released its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01), Bloomberg Earnings reports. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. During the same quarter in the prior year, the firm earned $0.21 earnings per share. The company’s revenue for the quarter was up .3% compared to the same quarter last year.

Monsanto (NYSE:MON) traded up $0.16 during trading hours on Friday, hitting $119.70. The company had a trading volume of 2,200,986 shares, compared to its average volume of 3,090,000. Monsanto has a 12-month low of $106.74 and a 12-month high of $122.79. The stock has a market capitalization of $52,690.00, a PE ratio of 22.13, a P/E/G ratio of 1.71 and a beta of 1.04. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s dividend payout ratio is currently 39.93%.

In related news, VP Nicole M. Ringenberg sold 7,890 shares of the stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now directly owns 38,600 shares of the company’s stock, valued at $4,718,850. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,310 shares of company stock valued at $2,458,328. 0.79% of the stock is owned by corporate insiders.

Several large investors have recently bought and sold shares of the company. Bruderman Asset Management LLC purchased a new stake in shares of Monsanto in the second quarter worth approximately $116,000. Tower Research Capital LLC TRC raised its holdings in shares of Monsanto by 230.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after buying an additional 750 shares during the period. Americafirst Capital Management LLC purchased a new stake in shares of Monsanto in the third quarter worth approximately $148,000. Penserra Capital Management LLC raised its holdings in shares of Monsanto by 13.0% in the second quarter. Penserra Capital Management LLC now owns 1,456 shares of the basic materials company’s stock worth $172,000 after buying an additional 168 shares during the period. Finally, Fieldpoint Private Securities LLC raised its holdings in shares of Monsanto by 100.6% in the second quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock worth $186,000 after buying an additional 790 shares during the period. 75.34% of the stock is owned by institutional investors and hedge funds.

Several research firms have commented on MON. Barclays reissued an “equal weight” rating and issued a $124.00 target price (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Wells Fargo & Co upped their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Finally, Jefferies Group reiterated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Friday, September 15th. Eleven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $126.40.

TRADEMARK VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/13/monsanto-mon-posts-earnings-results-misses-estimates-by-0-01-eps.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Earnings History for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply